Roche Pharma commits 1.5 billion Swiss franc investment in India over next five years
Written By : Ruchika Sharma
Published On 2025-10-05 09:00 GMT | Update On 2025-10-05 09:00 GMT
Advertisement
New Delhi: Swiss healthcare giant Roche Pharma has announced a major investment plan of 1.5 billion Swiss Francs in India over the next five years. The company’s commitment was revealed by Francois du Toit, Roche Pharma’s Area Head for Central Eastern Europe, Turkey, Russia, and the Indian Subcontinent, during his speech at the Prosperity Summit.
Du Toit emphasized that this significant investment highlights Roche's long-term commitment to the Indian market.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.